PMGC Holdings Inc. (ELAB)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $2.17M
- P/E ratio
- —
- EPS
- —
- Volume
- 967,741
- 52-week high
- —
- 52-week low
- —
- Open
- $1.08
- Day high
- $1.08
- Day low
- $1.00
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $590.08K | -$7.75M | — |
| 2024 | — | -$6.25M | — |
| 2023 | $1.71M | -$4.3M | -$0.40 |
| 2022 | $766.28K | -$1.8M | -$0.19 |
About PMGC Holdings Inc.
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.
- CEO
- Graydon Bensler
- Employees
- 34
- Country
- US
- IPO date
- Nov 21, 2023
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is PMGC Holdings Inc.'s stock price today?
- ELAB is trading at $1.07 as of Jul 20, 2026.
- What is PMGC Holdings Inc.'s market cap?
- PMGC Holdings Inc. (ELAB) has a market capitalization of $2.17M.
- Does PMGC Holdings Inc. pay a dividend?
- PMGC Holdings Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is PMGC Holdings Inc. in?
- PMGC Holdings Inc. operates in the Healthcare sector.